Boiron Group (Boiron SA) Overview
Pro stress-test →Boiron is engaged in the manufacture and distribution of homeopathic preparations and is the world's leading company in its sector. Founded in 1932, the company operates globally with a significant presence across Europe and international markets.
Strategic Profile
Pro stress-test →In 2025, Boiron had annual revenue of 501.11M EUR with 2.78% growth, demonstrating modest stability in a mature market. The company maintained a gross profit margin of 73.6% in the most recent fiscal year, reflecting strong cost management in homeopathic product manufacturing and distribution.
Competitive Landscape
Pro stress-test →Laboratoires Arkopharma and Teva Pharmaceutical Industries are competitors of Boiron. Boiron maintains the largest global share of the homeopathy market, but faces competition from generic homeopathic manufacturers and traditional pharmaceuticals. The market itself is challenged by regulatory scrutiny on homeopathy efficacy in developed markets.
Industry Context
Boiron Group (Boiron SA) operates in Homeopathic Pharmaceuticals / Alternative Medicine.
Key facts
Founded: 1932 · Headquarters: Lyon, France · Employees: ~2,634 · Revenue: €501.11M (2025 annual) · Market cap: $566M